SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
REduced Frequency ImmuNE Checkpoint Inhibition in Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy
- Status
- TERMINATED
- Phase
- NA
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
- Status
- SUSPENDED
- Phase
- NA
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PRT1419 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Community Based Strategies for Early Detection of Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2